The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors
Germ cell tumors (GCTs) are considered to be highly curable; however, there are major differences in the outcomes related to histology and anatomical localization. GCTs originating from the testis are, overall, sensitive to platinum-based chemotherapy, whereas GCTs originating from the mediastinum s...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e3ff7794ad124071bdac71a905542ee0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e3ff7794ad124071bdac71a905542ee0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e3ff7794ad124071bdac71a905542ee02021-11-11T17:14:01ZThe Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors10.3390/ijms2221117741422-00671661-6596https://doaj.org/article/e3ff7794ad124071bdac71a905542ee02021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11774https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Germ cell tumors (GCTs) are considered to be highly curable; however, there are major differences in the outcomes related to histology and anatomical localization. GCTs originating from the testis are, overall, sensitive to platinum-based chemotherapy, whereas GCTs originating from the mediastinum show a worse response, which remains largely unexplained. Here, we address the differences among GCTs from two different anatomical locations (testicular versus mediastinal/extragonadal), with a specific focus on the role of the P53 pathway. It was recently shown that GCTs with <i>TP53</i> mutations most often localize to the mediastinum. To elucidate the underlying mechanism, <i>TP53</i> knock-out lines were generated in cisplatin-sensitive and -resistant clones of the representative 2102Ep cell line (wild-type <i>TP53</i> testicular GCT) and NCCIT cell line (hemizygously mutated <i>TP53</i>, mutant <i>TP53</i> mediastinal GCT). The full knock-out of <i>TP53</i> in 2102Ep and resistant NCCIT resulted in an increase in cisplatin resistance, suggesting a contributing role for P53, even in NCCIT, in which P53 had been reported to be non-functional. In conclusion, these results suggest that <i>TP53</i> mutations contribute to the cisplatin-resistant phenotype of mediastinal GCTs and, therefore, are a potential candidate for targeted treatment. This knowledge provides a novel model system to elucidate the underlying mechanism of clinical behavior and possible alternative treatment of the <i>TP53</i> mutant and mediastinal GCTs.Dennis M. TimmermanThomas F. EleveldAd J. M. GillisCarlijn C. FriedrichsSanne HilleniusTessa L. RemmersSruthi SriramLeendert H. J. LooijengaMDPI AGarticlehuman malignant germ cell tumorsmediastinal germ cell tumorstesticular germ cell tumorscisplatin resistance<i>TP53</i>NCCITBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11774, p 11774 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
human malignant germ cell tumors mediastinal germ cell tumors testicular germ cell tumors cisplatin resistance <i>TP53</i> NCCIT Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
human malignant germ cell tumors mediastinal germ cell tumors testicular germ cell tumors cisplatin resistance <i>TP53</i> NCCIT Biology (General) QH301-705.5 Chemistry QD1-999 Dennis M. Timmerman Thomas F. Eleveld Ad J. M. Gillis Carlijn C. Friedrichs Sanne Hillenius Tessa L. Remmers Sruthi Sriram Leendert H. J. Looijenga The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors |
description |
Germ cell tumors (GCTs) are considered to be highly curable; however, there are major differences in the outcomes related to histology and anatomical localization. GCTs originating from the testis are, overall, sensitive to platinum-based chemotherapy, whereas GCTs originating from the mediastinum show a worse response, which remains largely unexplained. Here, we address the differences among GCTs from two different anatomical locations (testicular versus mediastinal/extragonadal), with a specific focus on the role of the P53 pathway. It was recently shown that GCTs with <i>TP53</i> mutations most often localize to the mediastinum. To elucidate the underlying mechanism, <i>TP53</i> knock-out lines were generated in cisplatin-sensitive and -resistant clones of the representative 2102Ep cell line (wild-type <i>TP53</i> testicular GCT) and NCCIT cell line (hemizygously mutated <i>TP53</i>, mutant <i>TP53</i> mediastinal GCT). The full knock-out of <i>TP53</i> in 2102Ep and resistant NCCIT resulted in an increase in cisplatin resistance, suggesting a contributing role for P53, even in NCCIT, in which P53 had been reported to be non-functional. In conclusion, these results suggest that <i>TP53</i> mutations contribute to the cisplatin-resistant phenotype of mediastinal GCTs and, therefore, are a potential candidate for targeted treatment. This knowledge provides a novel model system to elucidate the underlying mechanism of clinical behavior and possible alternative treatment of the <i>TP53</i> mutant and mediastinal GCTs. |
format |
article |
author |
Dennis M. Timmerman Thomas F. Eleveld Ad J. M. Gillis Carlijn C. Friedrichs Sanne Hillenius Tessa L. Remmers Sruthi Sriram Leendert H. J. Looijenga |
author_facet |
Dennis M. Timmerman Thomas F. Eleveld Ad J. M. Gillis Carlijn C. Friedrichs Sanne Hillenius Tessa L. Remmers Sruthi Sriram Leendert H. J. Looijenga |
author_sort |
Dennis M. Timmerman |
title |
The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors |
title_short |
The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors |
title_full |
The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors |
title_fullStr |
The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors |
title_full_unstemmed |
The Role of <i>TP53</i> in Cisplatin Resistance in Mediastinal and Testicular Germ Cell Tumors |
title_sort |
role of <i>tp53</i> in cisplatin resistance in mediastinal and testicular germ cell tumors |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/e3ff7794ad124071bdac71a905542ee0 |
work_keys_str_mv |
AT dennismtimmerman theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT thomasfeleveld theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT adjmgillis theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT carlijncfriedrichs theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT sannehillenius theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT tessalremmers theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT sruthisriram theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT leenderthjlooijenga theroleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT dennismtimmerman roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT thomasfeleveld roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT adjmgillis roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT carlijncfriedrichs roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT sannehillenius roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT tessalremmers roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT sruthisriram roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors AT leenderthjlooijenga roleofitp53iincisplatinresistanceinmediastinalandtesticulargermcelltumors |
_version_ |
1718432150616801280 |